SHP1 peptide (ab42772)
Our Abpromise guarantee covers the use of ab42772 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ELISA: 10-100ng/well, established in 96-well Nunc immunoplates where peptide was bound to plates for 2hrs in 0.1M sodium carbonate buffer, pH 8.5.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- 70 kda SHP1L protein70Z-SHPEC 188.8.131.52
- HCPHCPHHematopoietic cell phosphataseHematopoietic cell protein tyrosine phosphataseHematopoietic cell protein-tyrosine phosphataseHPTP1CProtein tyrosine phosphatase 1CProtein tyrosine phosphatase non receptor type 6Protein tyrosine phosphatase SHP1Protein-tyrosine phosphatase 1CProtein-tyrosine phosphatase SHP-1PTN6_HUMANPTP-1CPTP1CPTPN6SH PTP 1SH-PTP1SHP 1LSHP1SHP1LTyrosine-protein phosphatase non-receptor type 6
Contains 2 SH2 domains.
Contains 1 tyrosine-protein phosphatase domain.
modificationsPhosphorylated on serine and tyrosine residues.
SHP1 peptide images
All lanes : Anti-SHP1 (phospho S591) antibody (ab41436)
Lane 3 : human Jurkat cells treated with pervanadate (1 mM) for 30 min
Lane 4 : human Jurkat cells treated with pervanadate (1 mM ( for 30 min) and exposed to lambda phosphatase
Lane 5 : human Jurkat cells treated with pervanadate (1 mM) for 30 min with phospho-SHP1 (Ser-591) peptide
Lane 6 : human Jurkat cells treated with pervanadate (1 mM) for 30 min with non-specific phospho-serine peptide
References for SHP1 peptide (ab42772)
ab42772 has not yet been referenced specifically in any publications.